Gujarat Kidney & Super Speciality Ltd
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
- Market Cap ₹ 836 Cr.
- Current Price ₹ 106
- High / Low ₹ 123 / 98.2
- Stock P/E 90.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 98.4 %
- ROE 83.6 %
- Face Value ₹ 2.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.4%
- Debtor days have improved from 181 to 43.2 days.
- Company's working capital requirements have reduced from 64.7 days to 15.5 days
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0.00 | 4.77 | 35.17 | |
| 0.01 | 3.20 | 19.73 | |
| Operating Profit | -0.01 | 1.57 | 15.44 |
| OPM % | 32.91% | 43.90% | |
| 0.00 | 0.70 | 0.11 | |
| Interest | 0.00 | 0.04 | 0.53 |
| Depreciation | 0.00 | 0.28 | 2.93 |
| Profit before tax | -0.01 | 1.95 | 12.09 |
| Tax % | 0.00% | 25.13% | 24.73% |
| -0.01 | 1.45 | 9.11 | |
| EPS in Rs | -0.50 | 72.50 | 1.60 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 637% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 869% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 59% |
| Last Year: | 84% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | |
| Reserves | 0.17 | 10.69 | |
| 0.00 | 1.94 | ||
| 3.50 | 3.99 | ||
| Total Liabilities | 3.87 | 16.82 | |
| 2.67 | 9.74 | ||
| CWIP | 0.00 | 0.00 | |
| Investments | 0.01 | 0.00 | |
| 1.19 | 7.08 | ||
| Total Assets | 3.87 | 16.82 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0.00 | -2.11 | ||
| 0.00 | -7.35 | ||
| 0.00 | 10.63 | ||
| Net Cash Flow | 0.00 | 1.17 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 318.32 | ||
| Inventory Days | 317.90 | ||
| Days Payable | 2,825.81 | ||
| Cash Conversion Cycle | -2,189.58 | ||
| Working Capital Days | 114.01 | ||
| ROCE % | 19.55% |
Insights
In beta| Mar 2026 | |
|---|---|
| Acquired Ownership Stake - Ashwini Medical Centre % |
|
| Acquired Ownership Stake - Harmony Medicare Private Limited % |
|
| Acquired Ownership Stake - Parekhs Hospital Private Limited % |
|
| Acquired Ownership Stake - Patel Multispeciality Hospital and ICU % |
|
| Acquired Ownership Stake - Patel Pharmacy % |
|
| Acquisition Cost - Ashwini Medical Centre INR |
|
| Acquisition Cost - Harmony Medicare Private Limited INR |
|
| Acquisition Cost - Parekhs Hospital Private Limited INR |
|
| Acquisition Cost - Patel Multispeciality Hospital and ICU INR |
|
| Acquisition Cost - Patel Pharmacy INR |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
3 Mar - Company Secretary Mrs Niki Paresh Tiwari resigned; relieving date March 27, 2026; replacement process underway.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Feb
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
15 Feb - NCLT allowed voluntary revision of Board's Report and notes for FY2021-22 to FY2023-24; RoC filing and Rs.10,000 fee.
-
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025
15 Feb - No deviation in utilisation of Rs2,508,000,000 equity proceeds raised 24-12-2025.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Feb - Brickwork MA report (Dec 31, 2025): IPO proceeds Rs250.80cr; Rs50.04cr used; no deviations.
Annual reports
No data available.
Business Profile[1]
Gujarat Kidney and Super Speciality Limited is a regional healthcare operator in central Gujarat, running a chain of mid-sized multi-speciality hospitals focused on secondary and tertiary care.